Medical Marijuana Industry Continues Rapid Expansion As Leaders Acquire New Dispensary Sites

 Medical Marijuana Industry Continues Rapid Expansion As Leaders Acquire New
                               Dispensary Sites

PR Newswire

CORAL SPRINGS, Florida, February 5, 2014

CORAL SPRINGS, Florida, February 5, 2014 /PRNewswire/ --

Alternative care pioneers continue to grow market with increasing demand:
Zoned Properties^[^SM^], Inc. (OTC: ZDPY), GW Pharmaceuticals plc (NASDAQ:
GWPH), Growlife, Inc. (OTCBB: PHOT), Medbox, Inc. (OTC: MDBX) and Idenix
Pharmaceuticals Inc. (NASDAQ: IDIX)

Zoned Properties^[^SM^], Inc. (OTC: ZDPY) closes on site for 8th largest
medical marijuana dispensary in the state of Arizona. ZDPY, a lessor of land,
facilities, and equipment to the medical marijuana market in Arizona announces
that it has closed on all of the real estate associated with the approved site
for a medical marijuana dispensary located in Gilbert, Arizona for $1.115
million. The Town of Gilbert has already granted a conditional use permit and
approved the design of the property, which is properly zoned for a medical
marijuana dispensary. In the state of Arizona, only one dispensary is
permitted in each community health analysis area (CHAA) and a total of 99
licenses were awarded in a lottery held in August of 2012. Only one other
location for a dispensary exists in the Town of Gilbert, the 7^th largest
municipality in a state with a population over 6.6 million.

To read the full press release, please click
here:http://www.fnmprofiles.com/profiles-zdpy.html

Zoned Properties^[^SM^], Inc. CEO Marc Brannigan stated, "Gilbert, Arizona
adopted one of the more stringent zoning ordinances of any municipality in the
entire state. We feel this is a tremendous accomplishment as our first
completed commercial real estate transaction in the medical marijuana industry
in the state of Arizona."

GW Pharmaceuticals plc (NASDAQ: GWPH) a biopharmaceutical company focused on
discovering, developing and commercializing novel therapeutics from its
proprietary cannabinoid product platform, will announce on 5 February, 2014
its first quarter financial results for the period ending 31 December, 2013.
GW will also host a conference call the same day at 1:00 p.m. GMT (8:00 a.m.
EST). Conference call information will be provided in the financial results
press release. A replay of the call will also be available through the
Company's website (http://www.gwpharm.com) shortly after the call.

Growlife, Inc. (OTCBB: PHOT) a diversified company operating in the legal
cannabis industry which develops, and deploys products and services of legal
cannabis and FusionPharm, Inc. (FSPM), manufacturer of the PharmPod(TM)
professional cultivation system, recently announced that the Companies will
expand their collaboration agreement and begin offering a co-branded line of
specialized professional cultivation equipment components. The new line of
professional components will be co-branded under FusionPharm's PharmPod(TM)
brand name and GrowLife's Stealth Grow(TM) line of equipment. This co-branded
component line will initially include a line of professional hoods/reflectors
and will quickly be expanded to include a wide range of custom designed
components. The first shipment of components is anticipated to be available
for installation in FusionPharm's PharmPod(TM) system and to the general
public through the GrowLife network of hydroponic stores and websites in
February.

Medbox, Inc. (OTC: MDBX) a leader in providing industry specific consulting
services and patented systems to the medical and retail industries, announced
FINRA consent and issuance of a common stock dividend. The 100% stock
dividend issuance will have a record date of December 18^th, 2013, and a pay
date of February 3^rd, 2014. Management clarified that the class of shares to
receive the dividend is the common shares only and not the preferred class of
shares held by company executives. The shares are issued on a one-year
restricted basis.

Advanced Cannabis Solutions, Inc. (OTCBB: CANN) recently signed a definitive
agreement with Full Circle Capital Corporation, a closed-end investment
company.The agreement provides that the investment fund will initially
provide $7.5 million to the Company in the form of Senior Secured Convertible
Notes, subject to certain conditions.An additional $22.5 million can be
borrowed by Company with the mutual agreement of the Company and the
investment company. At least 95% of the loan proceeds will be used to acquire
properties which the Company, consistent with its business plan, will lease to
licensed cannabis growers.

Idenix Pharmaceuticals Inc. (NASDAQ: IDIX) a biopharmaceutical company engaged
in the discovery and development of drugs for the treatment of human viral
diseases, announced that the United States Patent and Trademark Office Patent
Trial and Appeal Board (USPTO) issued a decision in the first patent
interference proceeding (No. 105,871) concerning one of the Company's patent
applications (U.S. Patent Application 12/131,868) and an issued patent (U.S.
Patent 7,429,572) owned by Gilead Pharmasset LLC ("Gilead") that covers
certain 2'-methyl-2'-fluoro nucleoside compounds useful in the treatment of
the hepatitis C virus (HCV). The USPTO determined that Idenix is not entitled
to priority of invention and judgment was entered in favor of Gilead. "We
intend to challenge this decision in proceedings outside the USPTO. We are
confident in our patent portfolio and will continue to defend it vigorously,
and this specific matter before the USPTO represents just one part of our
overall effort," said Ronald Renaud, President and Chief Executive Officer at
Idenix. "Idenix has several patent families that provide coverage for
2'-methyl nucleoside compounds and 2'-methyl, 2'-fluoro nucleoside compounds
specifically."

FinancialNewsMedia.com is leading provider of third party publishing &news
dissemination services. If you would like more information regarding our news
coverage solutions, please visithttp://www.financialnewsmedia.com for more
details. Get an edge on the market with ourPremium News Alerts that are
FREE for a limited time athttp://www.financialnewsmedia.com/. Follow us on
Facebook:http://www.facebook.com/financialnewsmedia and
Twitter:http://twitter.com/FNMgroup. Sign up for our FREE SMS News alerts
delivered directly to your mobile phone by texting the word PRESS to
545454.(SMS alerts are free, however data rates may apply, check your
wireless plan for details.)

DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news
dissemination service provider, which disseminates electronic information
through multiple online media channels. FNMG is NOT affiliated in any manner
with any company mentioned herein. FNMG and its affiliated companies are a
news dissemination and financial marketing solutions provider and are NOT a
registered broker/dealer/analyst/adviser, holds no investment licenses and may
NOT sell, offer to sell or offer to buy any security. FNMG's market updates,
news alerts and corporate profiles are NOT a solicitation or recommendation to
buy, sell or hold securities. The material in this release is intended to be
strictly informational and is NEVER to be construed or interpreted as research
material. All readers are strongly urged to perform research and due
diligence on their own and consult a licensed financial professional before
considering any level of investing in stocks. The companies that are
discussed in this release may or may not have approved the statements made in
this release. FNMG is not liable for any investment decisions by its readers
or subscribers. Investors are cautioned that they may lose all or a portion
of their investment when investing in stocks. For current services performed
FNMG has been compensated one thousand four hundred dollars for news coverage
of the current press release issued by NXT-Id, Inc. by a non-affiliated third
party.

FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE. 

This release contains "forward-looking statements" within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E the
Securities Exchange Act of 1934, as amended and such forward-looking
statements are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. "Forward-looking statements"
describe future expectations, plans, results, or strategies and are generally
preceded by words such as "may", "future", "plan" or "planned", "will" or
"should", "expected," "anticipates", "draft", "eventually" or "projected". You
are cautioned that such statements are subject to a multitude of risks and
uncertainties that could cause future circumstances, events, or results to
differ materially from those projected in the forward-looking statements,
including the risks that actual results may differ materially from those
projected in the forward-looking statements as a result of various factors,
and other risks identified in a company's annual report on Form 10-K or 10-KSB
and other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue reliance on
such statements. The forward-looking statements in this release are made as of
the date hereof and FNMG undertakes no obligation to update such statements.

Contact Information:
Company: FN Media Group, LLC
Contact email: editor@financialnewsmedia.com
U.S. Phone: 1(954)345-0611
URL: http://www.financialnewsmedia.com

SOURCE FN Media Group, LLC
 
Press spacebar to pause and continue. Press esc to stop.